Insider Selling: USANA Health Sciences (NYSE:USNA) Director Sells 1,058 Shares of Stock
USANA Health Sciences (NYSE:USNA) Director Gilbert Fuller sold 1,058 shares of company stock on March 20th, 2026, for a total of $17,986.00 at an average price of $17.00 per share. The stock traded down to $16.88, near its 52-week low, despite the company beating quarterly EPS expectations. Institutional investors hold over 54% of the shares, and analyst ratings are mixed.
How this was made

The 30-second read
Why it matters
The insider sale amid a stock trading near its low and earnings beat suggests a cautious stance from management, possibly due to broader market concerns or personal portfolio adjustments.
Market read
While insider selling can signal caution, the company's recent earnings beat and sector stability suggest limited immediate downside. Traders should weigh insider activity against technical signals and broader market conditions.
What to watch
Market-wide volatility, macroeconomic conditions, and upcoming earnings reports could influence stock movement independently of insider activity.
Background
USANA Health Sciences recently reported quarterly earnings exceeding expectations, yet insider Gilbert Fuller sold 1,058 shares at an average price of $17.00, near the 52-week low.
Ticker impact
The insider selling activity and stock performance suggest cautious outlook.
Potential short-term decline or sideways movement; long-term impact uncertain.
Insider sales can be a normal part of portfolio management and do not always indicate negative outlook. The stock traded near its 52-week low despite earnings beats, suggesting other factors are influencing price.
Market effects
The consumer health and life sciences sector may experience minor volatility due to insider activity in USNA.
Limited; USNA's market cap and trading volume suggest minimal regional impact.
Negligible; USNA's activity is unlikely to influence global markets significantly.
Counterpoint
Insider selling may be routine profit-taking and not indicative of future performance; the company's earnings beat suggests underlying strength.
Key entities
- Insider/DirectorGilbert Fuller
Director of USANA Health Sciences who sold 1,058 shares.
- CompanyUSANA Health Sciences
A company in the life sciences sector specializing in consumer health products.




